The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure
Open accessAbstract
Background: Fibronectin (FN) polymerization is necessary for collagen matrix deposition and is a key contributor to increased abundance of cardiac myofibroblasts (MFs) after cardiac injury. We hypothesized that interfering with FN polymerization or its genetic ablation in fibroblasts would attenuate MF and fibrosis and improve cardiac function after ischemia/reperfusion (I/R) injury. Methods: Mouse and human MFs were used to assess the impact of the FN polymerization inhibitor (pUR4) in attenuating pathological cellular features such as proliferation, migration, extracellular matrix deposition, and associated mechanisms. To evaluate the therapeutic potential of inhibiting FN polymerization in vivo, wild-type mice received daily intraperitoneal injections of either pUR4 or control peptide (III-11C) immediately after cardiac surgery for 7 consecutive days. Mice were analyzed 7 days after I/R to assess MF markers and inflammatory cell infiltration or 4 weeks after I/R to evaluate long-term effects of FN inhibition on cardiac function and fibrosis. Furthermore, inducible, fibroblast-restricted, FN gene–ablated (Tcf21 MerCreMer ; Fn flox ) mice were used to evaluate cell specificity of FN expression and polymerization in the heart. Results: pUR4 administration on activated MFs reduced FN and collagen deposition into the extracellular matrix and attenuated cell proliferation, likely mediated through decreased c-myc signaling. pUR4 also ameliorated fibroblast migration accompanied by increased β1 integrin internalization and reduced levels of phosphorylated focal adhesion kinase protein. In vivo, daily administration of pUR4 for 7 days after I/R significantly reduced MF markers and neutrophil infiltration. This treatment regimen also significantly attenuated myocardial dysfunction, pathological cardiac remodeling, and fibrosis up to 4 weeks after I/R. Last, inducible ablation of FN in fibroblasts after I/R resulted in significant functional cardioprotection with reduced hypertrophy and fibrosis. The addition of pUR4 to the FN-ablated mice did not confer further cardioprotection, suggesting that the salutary effects of inhibiting FN polymerization may be mediated largely through effects on FN secreted from the cardiac fibroblast lineage. Conclusions: Inhibiting FN polymerization or cardiac fibroblast gene expression attenuates pathological properties of MFs in vitro and ameliorates adverse cardiac remodeling and fibrosis in an in vivo model of heart failure. Interfering with FN polymerization may be a new therapeutic strategy for treating cardiac fibrosis and heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., Ikonomidis, J. S., Khavjou, O., Konstam, M. A., Maddox, T. M., et al. (2013) · Circulation: Heart Failure · doi:10.1161/hhf.0b013e318291329a · Cited by 2,804
The inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
Formation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658
Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin
George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H., & Hynes, R. O. (1993) · Development · doi:10.1242/dev.119.4.1079 · Cited by 1,305
Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure
Chen, X., Nadiarynkh, O., Plotnikov, S., & Campagnola, P. J. (2012) · Nature Protocols · doi:10.1038/nprot.2012.009 · Cited by 985
ECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892
Self-citationFocal adhesion kinase and its signaling pathways in cell migration and angiogenesis
Zhao, X., & Guan, J.-L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.001 · Cited by 835
Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin.
Hanks, S. K., Calalb, M. B., Harper, M. C., & Patel, S. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8487 · Cited by 818
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
Fan, D., Takawale, A., Lee, J., & Kassiri, Z. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-15 · Cited by 814
Sottile, J., & Hocking, D. C. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-01-0048 · Cited by 645
Role of innate and adaptive immune mechanisms in cardiac injury and repair
Epelman, S., Liu, P. P., & Mann, D. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3800 · Cited by 634
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors
Miyake, K. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.002 · Cited by 522
Acharya, A., Baek, S. T., Huang, G., Eskiocak, B., Goetsch, S., Sung, C. Y., Banfi, S., Sauer, M. F., Olsen, G. S., Duffield, J. S., et al. (2012) · Development · doi:10.1242/dev.079970 · Cited by 498
Fibroblasts and Myofibroblasts: What Are We Talking About?
Baum, J., & Duffy, H. S. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182116e39 · Cited by 481
Jarnagin, W. R., Rockey, D. C., Koteliansky, V. E., Wang, S. S., & Bissell, D. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2037 · Cited by 452
3-Dimensional imaging of collagen using second harmonic generation
Cox, G., Kable, E., Jones, A., Fraser, I., Manconi, F., & Gorrell, M. D. (2003) · Journal of Structural Biology · doi:10.1016/s1047-8477(02)00576-2 · Cited by 430
Petrov, V. V., Fagard, R. H., & Lijnen, P. J. (2002) · Hypertension · doi:10.1161/hy0202.103268 · Cited by 419
Ahmed, S. H., Clark, L. L., Pennington, W. R., Webb, C. S., Bonnema, D. D., Leonardi, A. H., McClure, C. D., Spinale, F. G., & Zile, M. R. (2006) · Circulation · doi:10.1161/circulationaha.105.573865 · Cited by 386
Amati, B. (1998) · Frontiers in Bioscience · doi:10.2741/a239 · Cited by 367
Velling, T., Risteli, J., Wennerberg, K., Mosher, D. F., & Johansson, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206286200 · Cited by 357
McKeown-Longo, P. J., & Mosher, D. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.2.364 · Cited by 334
Danen, E. H. J., Sonneveld, P., Brakebusch, C., Fässler, R., & Sonnenberg, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200205014 · Cited by 333
Heling, A., Zimmermann, R., Kostin, S., Maeno, Y., Hein, S., Devaux, B., Bauer, E., Klövekorn, W.-P., Schlepper, M., Schaper, W., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.8.846 · Cited by 326
Entman, M. L., Youker, K., Shoji, T., Kukielka, G., Shappell, S. B., Taylor, A. A., & Smith, C. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115999 · Cited by 300
An essential role for fibronectin extra type III domain A in pulmonary fibrosis
Muro, A. F., Moretti, F. A., Moore, B. B., Yan, M., Atrasz, R. G., Wilke, C. A., Flaherty, K. R., Martinez, F. J., Tsui, J. L., Sheppard, D., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1291oc · Cited by 297
Caveolin-1-dependent β1 integrin endocytosis is a critical regulator of fibronectin turnover
Shi, F., & Sottile, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.014977 · Cited by 237
VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis
Sans, M., Panés, J., Ardite, E., Elizalde, J. I., Arce, Y., Elena, M., Palacín, A., Fernández–Checa, J. C., Anderson, D. C., Lobb, R., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70070-3 · Cited by 228
Fibronectin in cell adhesion and invasion
Ruoslahti, E. (1984) · Cancer and Metastasis Review · doi:10.1007/bf00047692 · Cited by 224
Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin
Sottile, J., Shi, F., Rublyevska, I., Chiang, H.-Y., Lust, J., & Chandler, J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00130.2007 · Cited by 191
Extracellular matrix remodeling in canine and mouse myocardial infarcts
Dobaczewski, M., Bujak, M., Zymek, P., Ren, G., Entman, M. L., & Frangogiannis, N. G. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0144-6 · Cited by 180
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro
Heng, B. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.12.022 · Cited by 173
Arslan, F., Smeets, M. B., Riem Vis, P. W., Karper, J. C., Quax, P. H., Bongartz, L. G., Peters, J. H., Hoefer, I. E., Doevendans, P. A., Pasterkamp, G., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.224428 · Cited by 172
Fibronectin Is an Important Regulator of Flow-Induced Vascular Remodeling
Chiang, H.-Y., Korshunov, V. A., Serour, A., Shi, F., & Sottile, J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181081 · Cited by 166
Extracellular matrix-mediated cellular communication in the heart
Valiente-Alandi, I., Schafer, A. E., & Blaxall, B. C. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.011 · Cited by 165
Self-citationFornaro, M., Plescia, J., Chheang, S., Tallini, G., Zhu, Y.-M., King, M., Altieri, D. C., & Languino, L. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307627200 · Cited by 155
TENASCIN AND FIBRONECTIN EXPRESSION IN HEALING HUMAN MYOCARDIAL SCARS
WILLEMS, I. E. M. G., Arends, J., & Daemen, M. J. A. P. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199607)179:3<321::aid-path555>3.0.co;2-8 · Cited by 152
Inhibition of fibronectin deposition improves experimental liver fibrosis
Altrock, E., Sens, C., Würfel, C., Vasel, M., Kawelke, N., Dooley, S., Sottile, J., & Nakchbandi, I. A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.010 · Cited by 137
A 49-Residue Peptide from Adhesin F1 of Streptococcus pyogenes Inhibits Fibronectin Matrix Assembly
Tomasini-Johansson, B. R., Kaufman, N. R., Ensenberger, M. G., Ozeri, V., Hanski, E., & Mosher, D. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103467200 · Cited by 126
Matrix metalloproteinases and myocardial infarction
Phatharajaree, W., Phrommintikul, A., & Chattipakorn, N. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70818-8 · Cited by 123
Fibronectin Is Essential for Reparative Cardiac Progenitor Cell Response After Myocardial Infarction
Konstandin, M. H., Toko, H., Gastelum, G. M., Quijada, P. J., Torre, A. D. L., Quintana, M., Collins, B. L., Din, S., Avitabile, D., Völkers, M., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301152 · Cited by 119
Han, S. W., & Roman, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209460 · Cited by 115
Ohnishi, T., Hiraga, S., Izumoto, S., Matsumura, H., Kanemura, Y., Arita, N., & Hayakawa, T. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006532812408 · Cited by 101
Zou, L. B., Cao, S., Kang, N., Huebert, R. C., & Shah, V. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304972 · Cited by 99
Insights into Extracellular Matrix Functions from Mutant Mouse Models
Gustafsson, E., & Fässler, R. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5042 · Cited by 78
Cao, Y., Liu, X., Lü, W., Chen, Y., Wu, X., Li, M., Wang, X.-A., Zhang, F., Jiang, L., Zhang, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.041 · Cited by 75
Increased Expression of Fibronectin Isoforms After Myocardial Infarction in Rats
Ulrich, M. M. W., Janssen, A. M. H., Daemen, M. J. A. P., Rappaport, L., Samuel, J., Contard, F., Smits, J. F. M., & Cleutjens, J. P. M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0486 · Cited by 74
Hernnäs, J., Nettelbladt, O., Bjermer, L. H., Särnstrand, B., Malmström, A., & Hällgren, R. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05040404 · Cited by 73
Lin, H.-Y., Tsai, C.-C., Chen, L., Chiou, S., Wang, Y.-J., & Hung, S. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-56 · Cited by 70
van Dijk, A., Niessen, H. W. M., Ursem, W., Twisk, J. W. R., Visser, F. C., & van Milligen, F. J. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0573-0 · Cited by 66
Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth
Konstandin, M. H., Völkers, M., Collins, B. L., Quijada, P. J., Quintana, M., Torre, A. D. L., Ormachea, L., Din, S., Gude, N. A., Toko, H., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0375-8 · Cited by 61
Straus, A. H., Carter, W. G., Wayner, E. A., et al. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90423-0 · Cited by 60
Integrin α8β1–fibronectin interactions promote cell survival via PI3 kinase pathway
Farias, E., Lü, M., Li, X., & Schnapp, L. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.125 · Cited by 41
Ensenberger, M. G., Tomasini-Johansson, B. R., Sottile, J., Ozeri, V., Hanski, E., & Mosher, D. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105417200 · Cited by 39
Effects of Depletion of CREB-binding Protein on c-Myc Regulation and Cell Cycle G1-S Transition
Rajabi, H. N., Baluchamy, S., Kolli, S., Nag, A., Srinivas, R., Raychaudhuri, P., & Thimmapaya, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408633200 · Cited by 34
Fibronectin in Immune Responses in Organ TransplantRecipients
Coito, A. J., de Sousa, M. A. B., & Kupiec‐Weglinski, J. W. (2000) · Journal of Immunology Research · doi:10.1155/2000/98187 · Cited by 23
Ensenberger, M. G., Annis, D. S., & Mosher, D. F. (2004) · Biophysical Chemistry · doi:10.1016/j.bpc.2004.07.020 · Cited by 23
Cited by
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.119.311148 · Cited by 520
The extracellular matrix in development
Walma, D. A. C., & Yamada, K. M. (2020) · Development · doi:10.1242/dev.175596 · Cited by 397
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 361
Metadata
- Authors
- Valiente-Alandi, I., Potter, S. J., Salvador, A. M., Schafer, A. E., Schips, T., Carrillo-Salinas, F., Gibson, A. M., Nieman, M. L., Perkins, C., Sargent, M. A., Huo, J., Lorenz, J. N., DeFalco, T., Molkentin, J. D., Alcaide, P., & Blaxall, B. C.
- Venue
- Circulation
- Published
- 2018-09-18
- Volume
- 138
- Issue
- 12
- Pages
- 1236-1252
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2797060729
- Cited by
- 261
- References
- 60
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.